Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTITHYROID ANTIBODY (ANTI-TPO) - ANVISA Registration 80048490070

Access comprehensive regulatory information for ANTITHYROID ANTIBODY (ANTI-TPO) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80048490070 and manufactured by MONOBIND INC.. The registration is held by USA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80048490070
Registration Details
ANVISA Registration Number: 80048490070
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

ANTI-THYROGLOBULIN (ANTI-TG)
Risk Class II

Registration Details

80048490070

25351007998201205

02330159000108

Company Information

MONOBIND INC.
United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Feb 27, 2012

VIGENTE

09/18/2025 19:00:01